Literature DB >> 22474068

Seipin: from human disease to molecular mechanism.

Bethany R Cartwright1, Joel M Goodman.   

Abstract

The most-severe form of congenital generalized lipodystrophy (CGL) is caused by mutations in BSCL2/seipin. Seipin is a homo-oligomeric integral membrane protein in the endoplasmic reticulum that concentrates at junctions with cytoplasmic lipid droplets (LDs). While null mutations in seipin are responsible for lipodystrophy, dominant mutations cause peripheral neuropathy and other nervous system pathologies. We first review the clinical aspects of CGL and the discovery of the responsible genetic loci. The structure of seipin, its normal isoforms, and mutations found in patients are then presented. While the function of seipin is not clear, seipin gene manipulation in yeast, flies, mice, and human cells has recently yielded a trove of information that suggests roles in lipid metabolism and LD assembly and maintenance. A model is presented that attempts to bridge these new data to understand the role of this fascinating protein.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22474068      PMCID: PMC3351812          DOI: 10.1194/jlr.R023754

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  73 in total

Review 1.  The multiple faces of caveolae.

Authors:  Robert G Parton; Kai Simons
Journal:  Nat Rev Mol Cell Biol       Date:  2007-03       Impact factor: 94.444

2.  Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations.

Authors:  Savitha Shastry; Mauricio R Delgado; Eray Dirik; Mehmet Turkmen; Anil K Agarwal; Abhimanyu Garg
Journal:  Am J Med Genet A       Date:  2010-09       Impact factor: 2.802

Review 3.  Generalized lipodystrophy, congenital and acquired (lipoatrophy).

Authors:  M Seip; O Trygstad
Journal:  Acta Paediatr Suppl       Date:  1996-06

4.  Lipid droplets are functionally connected to the endoplasmic reticulum in Saccharomyces cerevisiae.

Authors:  Nicolas Jacquier; Vineet Choudhary; Muriel Mari; Alexandre Toulmay; Fulvio Reggiori; Roger Schneiter
Journal:  J Cell Sci       Date:  2011-06-21       Impact factor: 5.285

5.  Seipin is a discrete homooligomer.

Authors:  Derk Binns; Sungkyung Lee; Christopher L Hilton; Qiu-Xing Jiang; Joel M Goodman
Journal:  Biochemistry       Date:  2010-11-18       Impact factor: 3.162

6.  Conditions of endoplasmic reticulum stress stimulate lipid droplet formation in Saccharomyces cerevisiae.

Authors:  Weihua Fei; Han Wang; Xin Fu; Christopher Bielby; Hongyuan Yang
Journal:  Biochem J       Date:  2009-10-23       Impact factor: 3.857

7.  Fat cell size and lipid content of subcutaneous tissue in congenital generalized lipodystrophy.

Authors:  T O Rognum; K S Bjerve; M Seip; O Trygstad; S Oseid
Journal:  Acta Endocrinol (Copenh)       Date:  1978-05

8.  The lipodystrophy protein seipin is found at endoplasmic reticulum lipid droplet junctions and is important for droplet morphology.

Authors:  Kimberly M Szymanski; Derk Binns; René Bartz; Nick V Grishin; Wei-Ping Li; Anil K Agarwal; Abhimanyu Garg; Richard G W Anderson; Joel M Goodman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-18       Impact factor: 11.205

9.  Mutations in the seipin and AGPAT2 genes clustering in consanguineous families with Berardinelli-Seip congenital lipodystrophy from two separate geographical regions of Brazil.

Authors:  Karina Braga Gomes; Ana Paula Fernandes; Alessandro Clayton Souza Ferreira; Hermes Pardini; Abhimanyu Garg; Jocelyne Magré; Victor Cavalcanti Pardini
Journal:  J Clin Endocrinol Metab       Date:  2004-01       Impact factor: 5.958

10.  Fld1p, a functional homologue of human seipin, regulates the size of lipid droplets in yeast.

Authors:  Weihua Fei; Guanghou Shui; Bruno Gaeta; Ximing Du; Lars Kuerschner; Peng Li; Andrew J Brown; Markus R Wenk; Robert G Parton; Hongyuan Yang
Journal:  J Cell Biol       Date:  2008-02-04       Impact factor: 10.539

View more
  55 in total

Review 1.  The collaborative work of droplet assembly.

Authors:  Xiao Chen; Joel M Goodman
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-07-12       Impact factor: 4.698

Review 2.  What the genetics of lipodystrophy can teach us about insulin resistance and diabetes.

Authors:  Camille Vatier; Guillaume Bidault; Nolwenn Briand; Anne-Claire Guénantin; Laurence Teyssières; Olivier Lascols; Jacqueline Capeau; Corinne Vigouroux
Journal:  Curr Diab Rep       Date:  2013-12       Impact factor: 4.810

Review 3.  Phenotypic and Genetic Characteristics of Lipodystrophy: Pathophysiology, Metabolic Abnormalities, and Comorbidities.

Authors:  Baris Akinci; Rasimcan Meral; Elif Arioglu Oral
Journal:  Curr Diab Rep       Date:  2018-11-08       Impact factor: 4.810

4.  [Role of lncRNA PTENP1 in tumorigenesis and progression of bladder cancer and the molecular mechanism].

Authors:  Gan Yu; Zheng-Yue Ou; Qi-Ye Tao; Guo-Yue Wan; Zong-Hao Lu; Bin Lang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-11-20

Review 5.  The assembly of lipid droplets and their roles in challenged cells.

Authors:  W Mike Henne; Michael L Reese; Joel M Goodman
Journal:  EMBO J       Date:  2018-05-22       Impact factor: 11.598

Review 6.  Expanding roles for lipid droplets.

Authors:  Michael A Welte
Journal:  Curr Biol       Date:  2015-06-01       Impact factor: 10.834

Review 7.  Lipid droplet dynamics in budding yeast.

Authors:  Chao-Wen Wang
Journal:  Cell Mol Life Sci       Date:  2015-04-18       Impact factor: 9.261

Review 8.  Lipid droplet formation on opposing sides of the endoplasmic reticulum.

Authors:  Stephen L Sturley; M Mahmood Hussain
Journal:  J Lipid Res       Date:  2012-06-14       Impact factor: 5.922

Review 9.  Skin manifestations in CDG.

Authors:  D Rymen; J Jaeken
Journal:  J Inherit Metab Dis       Date:  2014-02-20       Impact factor: 4.982

10.  Thiazolidinediones partially reverse the metabolic disturbances observed in Bscl2/seipin-deficient mice.

Authors:  X Prieur; L Dollet; M Takahashi; M Nemani; B Pillot; C Le May; C Mounier; H Takigawa-Imamura; D Zelenika; F Matsuda; B Fève; J Capeau; M Lathrop; P Costet; B Cariou; J Magré
Journal:  Diabetologia       Date:  2013-05-17       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.